Cargando…

Tailored Direct Oral Anticoagulation in Patients with Atrial Fibrillation: The Future of Oral Anticoagulation?

Direct oral anticoagulants (DOAC) are currently the drug of choice for drug prevention of stroke or systemic embolism in patients with atrial fibrillation (AF). However, repeated ischemic stroke or systemic embolism and bleeding while on DOAC is still a challenging clinical phenomenon in the managem...

Descripción completa

Detalles Bibliográficos
Autores principales:	Samoš, Matej, Bolek, Tomáš, Stančiaková, Lucia, Péč, Martin Jozef, Brisudová, Kristína, Škorňová, Ingrid, Staško, Ján, Mokáň, Marián, Kubisz, Peter
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9655219/ https://www.ncbi.nlm.nih.gov/pubmed/36362597 http://dx.doi.org/10.3390/jcm11216369

Ejemplares similares

Type 2 Diabetes, Atrial Fibrillation, and Direct Oral Anticoagulation
por: Prídavková, Dana, et al.
Publicado: (2019)

Does atorvastatin therapy change the anti‐Xa activity in xabans‐treated patients with atrial fibrillation?
por: Škorňová, Ingrid, et al.
Publicado: (2021)

Resistance on the Latest Oral and Intravenous P2Y12 ADP Receptor Blockers in Patients with Acute Coronary Syndromes: Fact or Myth?
por: Blaško, Peter, et al.
Publicado: (2022)

COVID-19 and the Response to Antiplatelet Therapy
por: Bolek, Tomáš, et al.
Publicado: (2023)

Viscoelastic Hemostatic Assays and Platelet Function Testing in Patients with Atherosclerotic Vascular Diseases
por: Samoš, Matej, et al.
Publicado: (2021)

Role of Thromboelastography and Rotational Thromboelastometry in the Management of Cardiovascular Diseases
por: Korpallová, Barbora, et al.
Publicado: (2018)

Rotational thromboelastometry in patients with type 2 diabetes and mild COVID-19 pneumonia: A pilot prospective study
por: Bolek, Tomáš, et al.
Publicado: (2022)

How to Treat Today? Oral and Facial Cancer-Associated Venous Thromboembolism
por: Janíčková, Mária, et al.
Publicado: (2023)

The Impact of Type 2 Diabetes on the Efficacy of ADP Receptor Blockers in Patients with Acute ST Elevation Myocardial Infarction: A Pilot Prospective Study
por: Samoš, Matej, et al.
Publicado: (2016)

SARS-CoV-2 Infection-Associated Aortic Thrombosis Treated with Oral Factor Xa Inhibition
por: Strýčková, Alena, et al.
Publicado: (2022)

Monitoring the hemostasis with rotation thromboelastometry in patients with acute STEMI on dual antiplatelet therapy: First experiences
por: Samoš, Matej, et al.
Publicado: (2017)

How can Secondary Thromboprophylaxis in High-Risk Pregnant Patients be Improved?
por: Stanciakova, Lucia, et al.
Publicado: (2022)

How Can Rotational Thromboelastometry as a Point-of-Care Method Be Useful for the Management of Secondary Thromboprophylaxis in High-Risk Pregnant Patients?
por: Stanciakova, Lucia, et al.
Publicado: (2021)

A Functional Assay for the Determination of Heparin-Induced Thrombocytopenia via Flow Cytometry
por: Skornova, Ingrid, et al.
Publicado: (2023)

Type 2 Diabetes and ADP Receptor Blocker Therapy
por: Samoš, Matej, et al.
Publicado: (2016)

Prevalence of oral anticoagulation in atrial fibrillation
por: Bartholomay, Eduardo, et al.
Publicado: (2014)

High On-Treatment Platelet Reactivity in Patients Undergoing Complex Percutaneous Coronary Interventions
por: Urban, Lukáš, et al.
Publicado: (2023)

The new oral anticoagulants in atrial fibrillation: an update
por: Verheugt, F. W. A.
Publicado: (2013)

Satisfaction with oral anticoagulants in patients with atrial fibrillation
por: Suárez Fernández, Carmen, et al.
Publicado: (2018)

Diabetic Heart Failure with Preserved Left Ventricular Ejection Fraction: Review of Current Pharmacotherapy
por: Benko, Jakub, et al.
Publicado: (2022)

Compliance and adherence to oral anticoagulation therapy in elderly patients with atrial fibrillation in the era of direct oral anticoagulants
por: Garkina, Svetlana V, et al.
Publicado: (2016)

Rivaroxaban as an oral anticoagulant for stroke prevention in atrial fibrillation
por: Turpie, Alexander GG
Publicado: (2014)

Novel oral Anticoagulants in Non-Valvular Atrial Fibrillation
por: da Silva, Rose M.F.L.
Publicado: (2014)

Characterization of patients with atrial fibrillation not treated with oral anticoagulants
por: Johansson, Cecilia, et al.
Publicado: (2014)

Oral Anticoagulants for Atrial Fibrillation Patients with Active Cancer
por: Kim, Do Young, et al.
Publicado: (2018)

Data on the use of oral anticoagulants in nonagenarians with atrial fibrillation
por: Giustozzi, Michela, et al.
Publicado: (2019)

Novel Oral Anticoagulants in Atrial Fibrillation: Update on Apixaban
por: Mezue, Kenechukwu, et al.
Publicado: (2017)

Oral Anticoagulation and Antiarrhythmic Drug Therapy for Atrial Fibrillation
por: Reiffel, James A.
Publicado: (2018)

The temporal context of oral anticoagulation outcome in atrial fibrillation
por: Fender, Anke C., et al.
Publicado: (2022)

Atrial Fibrillation and Ischemic Stroke despite Oral Anticoagulation
por: Galea, Roberto, et al.
Publicado: (2023)

Anticoagulation in Patients Aged ≥75 years with Atrial Fibrillation: Role of Novel Oral Anticoagulants
por: Ng, Kuan H., et al.
Publicado: (2013)

Direct Oral Anticoagulants in Old and Frail Patients with Atrial Fibrillation: The Advantages of an Anticoagulation Service
por: Vedovati, Maria Cristina, et al.
Publicado: (2022)

Patients and Their Physician’s Perspectives About Oral Anticoagulation in Patients With Atrial Fibrillation Not Receiving an Anticoagulant
por: Cannon, Christopher P., et al.
Publicado: (2023)

Effectiveness and safety of self-managed oral anticoagulant therapy compared with direct oral anticoagulants in patients with atrial fibrillation
por: Grove, Erik Lerkevang, et al.
Publicado: (2018)

Choice of Oral Anticoagulant: Outcomes in Atrial Fibrillation Patients Post-Stroke Despite Direct Oral Anticoagulant Use
por: Duong, Eric, et al.
Publicado: (2023)

Sticky platelets syndrome in a young patient with massive pulmonary embolism
por: Darulová, Stanislava, et al.
Publicado: (2013)

The Anti-Thrombotic Effects of PCSK9 Inhibitors
por: Péč, Martin Jozef, et al.
Publicado: (2023)

Veterans Perceptions of Satisfaction and Convenience with Anticoagulants for Atrial Fibrillation: Warfarin versus Direct Oral Anticoagulants
por: Mull, Hillary J, et al.
Publicado: (2020)

Tailored Anticoagulation for Thromboembolic Risk Reduction in Paroxysmal Atrial Fibrillation
por: Matos, Jason D., et al.
Publicado: (2018)

Underuse of oral anticoagulants in patients with nonvalvular atrial fibrillation in Italy
por: Ferro, D., et al.
Publicado: (2007)

Cannot write session to /tmp/vufind_sessions/sess_6vjqq8d86nkpoeoabnj1stuafr